Takeda Pharmaceutical Co., LTD et al v. Handa Pharmaceuticals, LLC

Filing 358

ORDER GRANTING re 272 Stipulation Concering Defendants' Proposed Redactions to the Court's Summary Judgment Order Pursuant to the Court's Order to File Summary Judgment Under Seal filed by Handa Pharmaceuticals, LLC, Par Pharmaceutical, Inc.. Signed by Judge Joseph C. Spero on 5/13/13. (klhS, COURT STAFF) (Filed on 5/13/2013)

1

(All parties and counsel listed on Signature Page)

2
3
4
5
6
7
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN FRANCISCO DIVISION

8
9
10
11
12

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

13
14
15
16
17

Plaintiffs,
v.
HANDA PHARMACEUTICALS, LLC AND
PAR PHARMACEUTICAL, INC.,
Defendants.

Case No. 11-cv-00840-JCS
Related Case Nos. 3:11-cv-01609-JCS and
3:11-cv-01610-JCS
STIPULATION CONCERNING
DEFENDANTS’ PROPOSED
REDACTIONS TO THE COURT’S
SUMMARY JUDGMENT ORDER
PURSUANT TO THE COURT’S
ORDER TO FILE SUMMARY
JUDGMENT UNDER SEAL
Judge:

Hon. Joseph C. Spero

18
19

WHEREAS, pursuant to the Court’s Order to File Summary Judgment Order Under Seal,

20

Docket No. 266, Defendants Handa Pharmaceuticals, LLC and Par Pharmaceutical, Inc.

21

(collectively, “Defendants”) have submitted proposed redactions to the Court’s order on the

22

parties’ summary judgment motions, Docket No. 265; and

23

WHEREAS, Plaintiffs do not oppose Defendants’ proposed redactions;

24

Plaintiffs and Defendants, by their undersigned attorneys, hereby stipulate, subject to the

25

approval of the Court, that the material identified by Defendants be filed under seal.

26
27
28
STIP. RE DEFS.’ PROPOSED
REDACTIONS TO SUMM. J. ORDER
CASE NO. 11-CV-0840-JCS

1

Respectfully Submitted,

2
Dated: April 15, 2013
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

By:
/s/ Mark T. Jansen
Mark T. Jansen (SBN 114896)
[e-mail]
Pilar R. Stillwater (SBN 260467)
[e-mail]
CROWELL & MORING LLP
275 Battery St., 23rd Fl.
San Francisco, CA 94111
Telephone: [phone]
Facsimile: [phone]
James K. Stronski
[e-mail]
Bruce D. DeRenzi
[e-mail]
Chiemi D. Suzuki
[e-mail]
Jacob Z. Zambrzycki
[e-mail]
CROWELL & MORING LLP
590 Madison Ave., 20th Fl.
New York, NY 10022-2524
Telephone: [phone]
Facsimile: [phone]
Keith J. Harrison
[e-mail]
CROWELL & MORING LLP
1001 Pennsylvania Ave., N.W.
Washington, DC 20004-2595
Telephone: [phone]
Facsimile: [phone]
Attorneys for Defendants
HANDA PHARMACEUTICALS, LLC AND
PAR PHARMACEUTICAL, INC.

21
22
23
24
25
26
27
28

By:
/s/ Heather E. Takahashi
Jeffrey I. Weinberger (SBN 056214)
[e-mail]
Ted G. Dane (SBN 143195)
[e-mail]
Heather E. Takahashi (SBN 245845)
[e-mail]
Ryan N. Hagglund (pro hac vice)
[e-mail]
MUNGER, TOLLES & OLSON LLP
355 South Grand Ave., 35th Floor
Los Angeles, CA 90071-1560
Telephone: [phone]
-1-

STIP. RE DEFS.’ PROPOSED
REDACTIONS TO SUMM. J. ORDER
CASE NO. 11-CV-0840-JCS

1

Facsimile: [phone]

2

Attorneys for Plaintiffs
TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA PHARMACEUTICALS
LLC, AND TAKEDA PHARMACEUTICALS
AMERICA, INC.

3
4
5

ER

R NIA

ERED
Spero

FO

seph C.

Judge Jo

H

11

RT

10

Dated: 5/13/13

NO

9

O ORD

IT IS S

A

8

LI

UNIT
ED

7

ISTRIC
ES D
TC
AT
T

RT
U
O

S

6

N

F
D IS T IC T O
R

C

12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-2-

STIP. RE DEFS.’ PROPOSED
REDACTIONS TO SUMM. J. ORDER
CASE NO. 11-CV-0840-JCS

1

Filer’s Attestation

2

I, Mark Jansen, am the ECF user whose identification and password are being used to file

3

this STIPULATION CONCERNING DEFENDANTS’ PROPOSED REDACTIONS TO

4

THE COURT’S SUMMARY JUDGMENT ORDER PURSUANT TO THE COURT’S

5

ORDER TO FILE SUMMARY JUDGMENT UNDER SEAL. In compliance with General

6

Order 45.X.B., I hereby attest that the other above-named signatories concur in this filing.

7

DATED: April 15, 2013
/s/ Mark T. Jansen

8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-3-

STIP. RE DEFS.’ PROPOSED
REDACTIONS TO SUMM. J. ORDER
CASE NO. 11-CV-0840-JCS